Neogen | NEOG - Cash And Equivalent


Neogen reported $172M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Agilent USD 1.76B 49M Jun/2026
Bio-Rad Laboratories USD 465.3M 51.7M Sep/2026
Cerus USD 19.96M 4.29M Dec/2025
Danaher USD 5.68B 1.33B Sep/2026
Idexx Laboratories USD 197.54M 603K Sep/2026
Illumina USD 1.29B 249M Sep/2026
Integra LifeSciences USD 252.26M 37.85M Sep/2026
Neogen USD 172M 13.5M Jun/2026
OraSure Technologies USD 160.58M 16.38M Jun/2026
Pacific Biosciences Of California USD 55.91M 5.1M Sep/2026
Quidel USD 166.4M 43M Sep/2026
Rockwell Medical USD 12.48M 1.09M Jun/2025
STAAR Surgical USD 133.61M 14.97M Sep/2026
Thermo Fisher Scientific USD 5.46B 1.4B Sep/2026
Utah Medical Products USD 84.27M 2.09M Sep/2025
Zoetis USD 1.33B 143M Sep/2026